Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2002
09/12/2002WO2002069907A2 Anti-neovasculature preparations for cancer
09/12/2002WO2002069890A2 Methods of identifying agents affecting atrophy and hypertrophy
09/12/2002WO2002069691A2 Immunogenic hiv peptides for use as reagents and vaccines
09/12/2002WO2002052031A3 Nucleic acid amplification
09/12/2002WO2002052012A3 Sugar beet genes involved in stress tolerance
09/12/2002WO2002049576A3 Fab i and inhibition of apicomplexan parasites
09/12/2002WO2002042771A3 Detection of binding reactions using catalytic electrochemical labels
09/12/2002WO2002027015A3 Assays for identifying receptors having alterations in signaling
09/12/2002WO2002022652A8 Haplotypes of the slc18a2 gene
09/12/2002WO2002016410A3 Peptide selection method
09/12/2002WO2002014369A3 Human kininogen d5 domain polypeptides and their use
09/12/2002WO2001081634A3 Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941
09/12/2002WO2001081626A3 Methods for clinical diagnosis
09/12/2002WO2001077684A3 Proteomic analysis using activity-based probe libraries
09/12/2002WO2001077335A3 Listeria monocytogenes genome, polypeptides and uses
09/12/2002WO2001077178A8 Compositions and methods for detection of von willebrand's disease
09/12/2002WO2001073118A3 Hybridisation beacon and method of rapid sequence detection and discrimination
09/12/2002WO2001069509A3 Clustering method
09/12/2002WO2001061036A3 A method of mapping restriction endonuclease cleavage sites
09/12/2002WO2001049721A3 Bacterial genes and proteins that are essential for cell viability and their uses
09/12/2002WO2001042467A3 Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
09/12/2002WO2001041752A3 Use of isoform specific inhibitors of cgmp-dependent protein kinase for treatment of pain
09/12/2002WO2001040519A3 Methods for identifying modulators for balance related disorders
09/12/2002WO2001038509A9 Method for the mutagenesis of nucleotide sequences from plants algae or fungi
09/12/2002WO2001036626A9 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds
09/12/2002WO2001035102A3 Diagnosis and treatment of malignant neoplasms
09/12/2002WO2001030848A3 Nucleic acids of the human abc1 gene and applications thereof
09/12/2002WO2001027329A3 Combinatorial oligonucleotide pcr: a method for rapid, global expression analysis
09/12/2002WO2001025485A3 Method for detecting mutations using arrayed primer extension
09/12/2002WO2001020034A3 Methods and compositions for the screening of cell cycle modulators
09/12/2002WO2001016372A9 Methods of immobilizing ligands on solid supports and apparatus and methods of use therefor
09/12/2002WO2001010203A3 Non-human transgenic animals for the study of neurodegenerative syndromes
09/12/2002WO2001009711A3 Methodology for identifying plants and other organisms having traits differing from a normal population
09/12/2002WO2001009386A3 Digital amplification
09/12/2002WO2001004360A9 Retroviral recombination assays and uses thereof
09/12/2002WO2001004322A9 Nucleotide sequences which code for the opca gene
09/12/2002WO2001002609A3 Method of identifying toxic agents using differential gene expression
09/12/2002WO2000075167A3 Phosphorylation assays
09/12/2002WO2000073801A3 Breast, gastric and prostate cancer associated antigens and uses therefor
09/12/2002WO2000068432A3 Diagnosis of primary congenital glaucoma
09/12/2002WO2000065091A3 Method of identifying ligands for the peroxisome proliferator activated receptor gamma using differential gene expression
09/12/2002WO2000063435A3 Method of identifying toxic agents using differential gene expression
09/12/2002WO2000058509A3 Prostate cancer associated human fibronectin gene and biallelic markers
09/12/2002WO2000053616A3 Nucleotides and polynucleotides immobilised on a solid support via a disulphide linkage
09/12/2002US20020129402 Generating disease resistant plants; obtain cells, transform, regenerate plant, evaluate resistance to soybean sudden death
09/12/2002US20020129401 Nucleotide sequences coding enzymatic protein for use in textile and wood treatment
09/12/2002US20020129398 Transfection, storage and transfer of male germ cells for generation of trangenic species
09/12/2002US20020129395 Compositions to identify swine genetically resistant to F18 E. coli associated diseases
09/12/2002US20020129391 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease
09/12/2002US20020129389 Method for determining the in vivo function of DNA coding sequences
09/12/2002US20020129388 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of atherosclerosis
09/12/2002US20020128781 Statistical combining of cell expression profiles
09/12/2002US20020128578 Comprising sheet having microchannels that permit directional flow of liquid; wound dressings, wound drains, tympanostomy fluid wicks; drug delivery
09/12/2002US20020128476 Inhibitors of cysteine protease
09/12/2002US20020128465 Charge tags and the separation of nucleic acid molecules
09/12/2002US20020128464 Nucleotide sequences coding enzymatic polypeptide for use in generating geetically engineered herbicide sensitive plants
09/12/2002US20020128451 Phthalamide-lanthanide complexes for use as luminescent markers
09/12/2002US20020128444 Controling abberant inflamatory response; obtain animal, incubate with modulator of inflammation, monitor animal for adjustment in inflammatory response
09/12/2002US20020128443 Polynucleotides encoding thrombin receptor homologs
09/12/2002US20020128437 Polypeptide for use in the detection of bactericides and prevention, detect and treatment of infections
09/12/2002US20020128436 Therapeutic composition for use in the treatment of autoimune and rheumatic diseases
09/12/2002US20020128319 Abeta 42 lowering agents
09/12/2002US20020128215 Polymorphisms of the NAT-2 gene which can be involved in drug metabolism and various disorders; pharmacogenetics
09/12/2002US20020128200 Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen tyrosinase derived peptides, and methods for treating said individuals
09/12/2002US20020128192 Insecticides against coleopteran insects including red flour beetle larvae and Japanese beetle larvae (Popillia japonica); transgenic plants having genes encoding crystal protein or peptide; immunodetection kits
09/12/2002US20020127855 Method for fabricating a pattern in a mask on a surface of an object and product manufactured thereby
09/12/2002US20020127740 Isolating preferential particles from solution; obtain probe, immobilize in reaction zone, transport fluid to reaction zone, detect and recover bound particles
09/12/2002US20020127738 Device for performing an assay, a method for manufacturing said device, and use of a membrane in the manufacture of said device
09/12/2002US20020127732 Diagnosing physiological defects; obtain sample, incubate with solid suport, detect label, evaluate for defect
09/12/2002US20020127715 Adjusting gene expression in preferential cells; obtain pluripotent cells, transform, monitor gene expression, compare to control, detect adjustment in gene expression
09/12/2002US20020127714 Detecting gene expression inhibitor for use in treatment of cancer; obtain nucleotide sequence of allele, incubate with gene expression inhibitor, monitor reduction in gene expression
09/12/2002US20020127708 Nucleic acid amplification reaction station for disposable test devices
09/12/2002US20020127700 Methods for improved diagnosis and treatment of mycobacterial infections
09/12/2002US20020127699 Kit for use in the detection preferential micoroganisms in sample
09/12/2002US20020127695 Enzymatic polypeptide for use in detergent and stain removal
09/12/2002US20020127694 2786, a novel human aminopeptidase
09/12/2002US20020127693 Reagents and methods useful for detecting diseases of the gastrointestinal tract
09/12/2002US20020127689 Novel human galectins
09/12/2002US20020127688 Detecting modulators of enzymes associated with transcriptional activities; obtain cells, incubate with modulators, monitor adjustment in enzyme activities
09/12/2002US20020127684 Novel cark protein and nucleic acid molecules and uses therefor
09/12/2002US20020127668 Polypeptide for use in the diagnosis and treatment of cancer, nervous system and vessicular transport disorders
09/12/2002US20020127666 Useful for production of intermediates in the adipic acid biosynthetic pathway or for the production of related molecules
09/12/2002US20020127663 Nucleotide sequences coding enzymatic polypeptide for use in human generation of amino acids for use in human therapeutics and animal nutrients
09/12/2002US20020127659 Recovering antibiotic biosynthetic nucleotide sequences from soil microorganisms; obtain soil sample, recover nucleotide sequences from soil microorganisms, incubate with primers, amplify, recover nucleotide sequence products
09/12/2002US20020127648 Novel human C5a-like receptor
09/12/2002US20020127647 ATP-binding cassette transporter-like molecules and uses thereof
09/12/2002US20020127646 CD38 modulated chemotaxis
09/12/2002US20020127644 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/12/2002US20020127638 Human metabotropic glutamate receptor 7 subtypes
09/12/2002US20020127636 Ankyrin repeat domain 2 protein variant
09/12/2002US20020127634 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
09/12/2002US20020127630 Filtration apparatus for use in measurement and monitoring microrganismal propagation in culture
09/12/2002US20020127629 Imaging of enzymatic activity
09/12/2002US20020127628 Diagnosing cancer in humans; obtain body fluid, incubate with cleaving enzyme and ethanolamine-1-phosphate, determine concentration of spingosine-1-phosphate in sample, evaluate for cancer
09/12/2002US20020127627 Measuring diacylglycerol acetyltransferase activity; obtain enzmatic substrate, expose to microsomes, terminate reaction, monitor triglyceride generation
09/12/2002US20020127623 Detecting preferential particles in sample; obtain preferential fusion protein, join to support, incubate with sample, detect confromational changes associate with bound protein
09/12/2002US20020127621 KUZ, a novel family of metalloproteases
09/12/2002US20020127612 Cell proliferation polypeptide for use in the diagnosis and treatment of tumors
09/12/2002US20020127610 Enhanced sensitivity coupled fiber-optic biosensor configurations
09/12/2002US20020127609 Screening for enzyme stereoselectivity; obtain substrates, label, measure through mass spectroscopy